← Open Payments lookup

AMY ADAMS: Open Payments

NPI 1306416268 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$784 in 53 payments from 12 companies in 2025. Trend: 2023 $1,573 · 2024 $1,332 · 2025 $784

Food & beverage: $784
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.16$167
Vanda Pharmaceuticals Inc.11$150
Alkermes, Inc.6$89
Teva Pharmaceuticals USA, Inc.5$84
Janssen Pharmaceuticals, Inc3$67
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$57
Supernus Pharmaceuticals, Inc.2$42
Neurocrine BioSciences, Inc.2$37
Lundbeck LLC2$35
Corium, LLC1$22

Products named: REXULTI, ARISTADA, HETLIOZ, FANAPT, CAPLYTA, AUSTEDO XR, Qelbree, INVEGA SUSTENNA.

Industry payments across KS — which companies pay providers there.